On Demand Webinars

31. The mRNA Journey: From Design To LNP-Ready Molecules For Research 11/25/2025

    Learn a validated, end-to-end protocol for producing high-quality in vitro transcription (IVT) mRNA for preclinical research. Find out how to optimize sequence design, small-scale synthesis, and more.

32. Hear From The Experts: LNPs Driving The Future Of Cell Therapy 12/12/2025

    Explore how lipid nanoparticles are driving breakthroughs in cell therapy, from mRNA-based immune cell engineering to genome editing for CAR T cells and HSPCs from leading experts.

33. Sustainable Vaccine Manufacturing: Securing The Future Of Global Health 7/22/2025

    Explore how next-gen technologies, from mRNA platforms to digital tools, are transforming vaccine manufacturing to make it more sustainable, flexible, and accessible.

34. New Approaches For Targeted Drug Delivery With Nanomedicines 4/13/2022

    Nanomedicine is a branch of medicine that seeks to apply nanotechnology for disease prevention and/or treatment, imaging, diagnosis, monitoring, and the repair and regeneration of biological systems.

35. Can Your Cleaning And Monitoring Withstand Regulatory Scrutiny? 7/25/2025

    Explore facility cleaning, monitoring, and disinfection strategies to meet regulatory standards, emphasizing planning, stakeholder involvement, testing, documentation, and improvement.

36. Are You Keeping Pace With Oligo Synthesis Optimization? 11/18/2025

    The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.

37. Accelerate Your pDNA And mRNA Process Development 11/13/2025

    Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.

38. Harnessing mRNA Quality Insights: Essential Techniques For Rapid Drug Development 11/11/2024

    Chief Scientific Officer and Founder Christian Cobaugh, Ph.D., examines the critical quality attributes of mRNA and LNPs that are pivotal to enhancing drug efficacy and safety.

39. Scalable Production Of Lentivirus For Research To Commercial Manufacturing 10/30/2024

    Join our webinar on scaling the CTS LV-MAX System in bioreactors, covering transfection scalability, Thermo S.U.B. advantages, and DynaSpin’s efficient gene therapy integration.

40. Regulatory Guidance For Bioprocessing Software 2/9/2022

    Gain an understanding of the regulatory requirements for software in a biopharmaceutical GxP environment and how software is invaluable for creating an audit trail, reporting, and automating regulatory-related tasks.